Onclara™ (by Onc.ai)
Overview
Onc.ai is a digital health company dedicated to radically improving oncology decision-making through advanced AI. Their flagship Onclara™ platform leverages a market-leading real-world oncology dataset to train best-in-class predictive and prognostic AI models. This technology aims to provide physicians and pharmaceutical companies with deeper insights for more effective cancer treatment strategies and clinical trial management.
The Onclara™ platform offers two primary products: Onclara™ Evaluate and Onclara™ IO. This product helps optimize trial design and patient selection, potentially accelerating the development of new cancer therapies.
Onclara™ IO focuses on clinical practice, specifically predicting response and outcomes for patients with metastatic lung cancer treated with immunotherapy. By providing prognostic insights, Onclara™ IO can assist physicians in personalizing treatment plans and managing patient expectations more effectively. The platform’s models are continuously validated against comprehensive real-world datasets, ensuring their relevance and accuracy in a clinical setting.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered predictive and prognostic models
- Leverages real-world oncology datasets
- Improves Phase IB/Phase II clinical trial decision-making
- Predicts response and outcomes for metastatic lung cancer with immunotherapy
- Imaging AI for oncology
- Serial Imaging Response Score (SIRS)
- Validated on comprehensive real-world datasets (e.g., Flatiron Health)
Use Cases
- Optimizing oncology clinical trial design and patient selection
- Predicting immunotherapy response in metastatic lung cancer
- Personalizing cancer treatment plans
- Early assessment of NSCLC immunotherapy outcomes
- Enhancing clinical decision-making in oncology
What Physicians Need to Know
Onclara™ offers AI-powered insights for predicting response and outcomes in metastatic lung cancer patients treated with immunotherapy. It also provides tools to improve decision-making in Phase IB/Phase II clinical trials.
The platform leverages a real-world dataset from Flatiron Health for validation and model training.
Details
| Category | Clinical Decision Support & Reference, Oncology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-hosted (Onclara™ Studio, Microsoft Azure Foundry) |
| Mobile App | OncoCare (by Onco AI) is available on the Apple App Store, but it is unclear if this is directly related to Onc.ai's Onclara™ platform. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pulmonology, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Onclara™ (by Onc.ai)
Videos
Product demos, reviews, and walkthroughs for Onclara™ (by Onc.ai).
No videos found. Search YouTube directly
Frequently Asked Questions
Compare Onclara™ (by Onc.ai)
VS
VS
VS
VS
Investors who backed Onclara™ (by Onc.ai)
Funded through the company that built this tool.




